Phase I trial outcome of amnion cell therapy in patients with ischemic stroke (I-ACT)

Overview of attention for article published in Frontiers in Neuroscience, May 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 74,700 followers.

New Research: Phase I trial outcome of amnion cell therapy in patients with ischemic stroke (I-ACT): Background We proposed a Phase I dose escalation trial to assess the safety of allogeneic human amniotic epithelial cells (hAECs) in… #Neuroscience https:

28 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.